GLA

Faculty

Dr. Pankaj Garg

Assistant Professor - Institute of Applied Sciences & Humanities

Department

Department of Chemistry

Experience

17 Years

Dr. Pankaj Garg

Ph.D Thesis Supervised

1

Awarded/
Completed

1

Working

Qualifications

  • JRF, PhD

Publication

−
  • Krishna M, Garg P, Horne D, Salgia R, Singhal SS. Inflammation-driven transcriptional reprogramming in prostate cancer: Convergence of NFκB, JAK/STAT3, and epigenetic remodeling in castration-resistant disease. Cancer Letters. 2026;655:218647. doi:10.1016/j.canlet.2026.218647 (Impact Factor -10.7 – Q1)
  • Pankaj Garg, Horne D, Salgia R, Singhal SS. AI-Driven Design of High Affinity Biomolecule–Drug Conjugates for Gynecological Cancer Therapy: An Up-to-Date Narrative Review. Cancers. 2026;18:1856. https://doi.org/10.3390/cancers18111856 (Impact Factor=4.9-Q2)
  • Pankaj Garg, Horne D, Salgia R, Singhal SS. Engineering nanozymes for cancer theranostics: Chemical design, catalytic intelligence, and translational oncology frontiers. Transl Oncol. 2026;70:102851. doi:10.1016/j.tranon.2026.102851 (Impact Factor=4.7-Q2)
  • Garg P, Salgia R, Singhal SS. Chemoresistance in gynecologic cancers: mechanistic insights and emerging platforms to overcome drug failure. J Ovarian Res. 2026;19:162. https://doi.org/10.1186/s13048-026-02115-9 (Impact Factor=5.2-Q1)
  • Garg P, Salgia R, Singhal SS. mRNA-based cancer vaccines: A new frontier in personalized immunotherapy. Biochim Biophys Acta Rev Cancer. 2026;1881(3):189577. doi:10.1016/j.bbcan.2026.189577 (IF=11.7-Q1)
  • Garg P, Krishna M, Singhal SS. Small but mighty: Peptides as next-generation immunotargeting agents in gynecological cancers. Transl Oncol. 2026;67:102751. doi:10.1016/j.tranon.2026.102751 (IF=4.9-Q2)
  • Garg P, Singhal G, Singhal SS. Next-generation viral detection through AI-enhanced nanotechnology: advances, challenges, and future directions. Front Mol Biosci. 2026;13:1750124. https://doi.org/10.3389/fmolb.2026.1750124 (IF=4.9-Q2)
  • Garg P, Salgia R, Singhal SS. Epitranscriptomic signatures of malignancy: how RNA modifications shape breast and ovarian tumor progression. Biochem Pharmacol. 2026;248:117872. https://doi.org/10.1016/j.bcp.2026.117872 (IF=6.7-Q1)
  • Krishna BM, Garg P, Ramisetty S, Nair M, Kulkarni P, Horne D, Wang E, Salgia R, Singhal SS. Emerging trends and treatment strategies in ovarian cancer: A comprehensive review. Crit Rev Oncol Hematol. 2026;220:105177. https://doi.org/10.1016/j.critrevonc.2026.105177 (IF=5.9-Q1)
  • Garg P, Krishna M, Kulkarni P, Horne D, Salgia R, Singhal SS. Machine Learning Models for Predicting Gynecological Cancers: Advances, Challenges, and Future Directions. Cancers. 2025;17(17):2799. https://doi.org/10.3390/cancers17172799 (IF=4.9-Q2)
  • Garg P, Ramisetty S, Nair M, Kulkarni P, Horne D, Salgia R, Singhal SS. Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy. Biochem Pharmacol. 2025;236:116850. https://doi.org/10.1016/j.bcp.2025.116850 (IF=6.7-Q1)
  • Garg P, Singhal G, Horne D, Salgia R, Singhal SS. Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics. Biochim Biophys Acta Rev Cancer. 2025;1880(5):189396. https://doi.org/10.1016/j.bbcan.2025.189396 (Impact Factor-11.43-Q1)
  • Garg P, Singhal G, Horne D, Kulkarni P, Salgia R, Singhal SS. Molecular PET imaging: Unlocking the secrets of cancer metabolism. Biochem Pharmacol. 2025;242(Pt 3):117202. https://doi.org/10.1016/j.bcp.2025.117202 (IF=6.7-Q1)
  • Garg, P., Singhal, G., Horne, D., Kulkarni, P., Salgia, R., Singhal, S. S. (2025). Molecular PET imaging: Unlocking the secrets of cancer metabolism. Biochemical Pharmacology, 242(Pt 3), 117202. https://doi.org/10.1016/j.bcp.2025.117202 (IF=6.7 – Q1)
  • Pankaj Garg, Singhal G, Pareek S, et al. Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview. Biochim Biophys Acta Rev Cancer. 2025;1880(1):189233. doi:10.1016/j.bbcan.2024.189233 (Impact Factor-11.43-Q1)
  • Pankaj Garg, Sravani Ramisetty, Meera Nair, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy. Biochemical Pharmacology. 2025;236:116850. https://doi.org/10.1016/j.bcp.2025.116850. (Impact Factor 5.3-Q1)
  • Pankaj Garg, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS. Exploring the potential of TGFβ as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol. 2025;231:116646. doi:10.1016/j.bcp.2024.116646 (Impact Factor 5.3-Q1)
  • Pankaj Garg, Singhal G, Kulkarni P, Horne D, Salgia R, Singhal SS. Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer Drugs. Cancers. 2024;16(22):3884. https://doi.org/10.3390/cancers16223884 (Impact Factor 5.2-Q1)
  • Pankaj Garg, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS. Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment. Journal of Clinical Medicine. 2024;13(21):6537. https://doi.org/10.3390/jcm13216537 (Impact Factor-4.96-Q2)
  • Krishna BM, Pankaj Garg, Ramisetty S, et al. Comprehensive investigation of long non-coding RNA HOTAIR polymorphisms and cancer risk: a current meta-analysis encompassing 96,458 participants. Scientific Reports. 2024;14:22670. https://doi.org/10.1038/s41598-024-72586-7
  • Pankaj Garg, Krishna M, Subbalakshmi AR, et al. Emerging biomarkers and molecular targets for precision medicine in cervical cancer. Biochim Biophys Acta Rev Cancer. 2024;1879(3):189106. doi:10.1016/j.bbcan.2024.189106 (Impact Factor-11.43-Q1)
  • Pankaj Garg, Pareek S, Kulkarni P, Salgia R, Singhal SS. Nanoengineering Solutions for Cancer Therapy: Bridging the Gap between Clinical Practice and Translational Research. Journal of Clinical Medicine. 2024;13(12):3466. https://doi.org/10.3390/jcm13123466 (Impact Factor-4.96-Q2)
  • Pankaj Garg, Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Madhu Krishna, Siddhika Pareek, Atish Mohanty, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential. Biochemical Pharmacology. 2024;116498. https://doi.org/10.1016/j.bcp.2024.116498 (Impact factor-5.86-Q1)
  • Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells. Cancers. 2024;16(13):2478. https://doi.org/10.3390/cancers16132478 (Impact factor-5.2-Q1)
  • Pankaj Garg, Singhal S, Kulkarni P, Horne D, Malhotra J, Salgia R, Singhal SS. Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. Journal of Clinical Medicine. 2024;13(14):4189. https://doi.org/10.3390/jcm13144189 (Impact factor 4.96)
  • B Madhu Krishna, Sravani K Ramisetty, Pankaj Garg, Atish Mohanty, Edward Wang, David Horne, Sanjay Awasthi, Prakash Kulkarni, Ravi Salgia, Sharad S Singhal. Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter. Carcinogenesis. 2024; bgae047. https://doi.org/10.1093/carcin/bgae047
  • Pankaj Garg, Rachana Garg, David Horne, Sanjay Awasthi, Ravi Salgia, Sharad S. Singhal. Prognostic significance of natural products against multidrug tumor resistance. Cancer Letters. 2023;557:1–16. https://doi.org/10.1016/j.canlet.2023.216079 (SCI-Q1; Impact Factor-9.756)
  • Pankaj Garg, Sanjay Awasthi, David Horne, Ravi Salgia, Sharad S. Singhal. The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2023;1878(4):188929. DOI:10.1016/j.bbcan.2023.188929 (SCI-Q1; Impact Factor-11.43)
  • Sharad S. Singhal, Rachana Garg, Atish Mohanty, Pankaj Garg, Sravani Keerthi Ramisetty, Tamara Mirzapoiazova, Raffaella Soldi, Ravi Salgia. Recent Advancement in Breast Cancer Research: Insights from Model Organisms - Mouse Models to Zebrafish. Cancers. 2023;15(11):1–29. https://doi.org/10.3390/cancers15112961 (SCI-Q1; IF=6.639)
  • Richa, Akhilesh Kumar, Indresh Verma, Pankaj Garg, Rohan D. Erande, Saleem Javed. Magnetic properties and pH-controlled reversible interconversion of µ-oxido into µ-hydroxido in oxo-carboxylato bridged iron(III) dimers: Theoretical and experimental insights. Journal of Molecular Structure. 2023;1285:135426. https://doi.org/10.1016/j.molstruc.2023.135426 (SCI; IF=3.841)
  • Pankaj Garg, Sharad S. Singhal. The Potential of 3,6 Dihydroxyflavone Embedded Gold Nanoparticles for Inhibition of Tumor Growth in Presence of Dietary Supplements. Current Trends in Internal Medicine. 2022;6:175. (IF=2.10)
  • Aysha Fatima, Akram Ali, Ramya Rajan, Indresh Verma, S. Muthu, Nazia Siddiqui, Pankaj Garg Saleem Javed. Experimental Spectroscopic, DFT, Molecular Docking, and Molecular Dynamics Simulation Investigations on m-Phenylenediamine (Monomer and Trimer). Polycyclic Aromatic Compounds. 2022. DOI:10.1080/10406638.2022.2150655 (SCI; IF=2.195)
  • Pankaj Garg. Carbon Nanotubes (CNTs): Smart Theranostic Tools for the Recognition and Preclusion of SARS-COV Variants. Nano LIFE. 2022;12(4):2250012. DOI:10.1142/S179398442250012X
  • Aysha Fatima, Himanshu Arora, Prabuddha Bhattacharya, Nazia Siddiqui, Khamael M. Abualnaja, Pankaj Garg, Saleem Javed. DFT, Molecular Docking, Molecular Dynamics Simulation (MMGBSA) and Hirshfeld Surface Analysis of 5-Sulfosalicylic Acid. Journal of Molecular Structure. 2022;1273:134242. DOI:10.1016/j.molstruc.2022.134242
  • Pankaj Garg. Radiobioconjugate targeted therapy in cancer, using radiolabeled biological analogs: Desired qualities and selective targeting approach. Biomedical and Biotechnology Research Journal. 2022;6(1):40–49. DOI:10.4103/bbrj.bbrj_282_21
  • Pankaj Garg. Pretargeting Articulation for Improving the Deliverance of Injected Dose to the Tumor. An Evaluation of In Vivo Study for Enhanced Tumor Uptake. Biomedical and Biotechnology Research Journal. 2022;6(3):387–393. DOI:10.4103/bbrj.bbrj_149_22
  • Pankaj Garg. The New Variants of Corona-Virus Mutations: An Understanding to Their Infectivity, Immunological Tolerance and Vaccine Efficacy. Nano-Life. 2021;11(3):2130010. DOI:10.1142/S1793984421300107
  • Pankaj Garg. Selective Preference of Antibody Mimetics over Antibody, as Binding Molecules, for Diagnostic and Therapeutic Applications in Cancer Therapy. Bio-Interface Research in Applied Chemistry. 2021;11(3):10765–10775. DOI:10.33263/BRIAC113.1076510775
  • Pankaj Garg. Convalescent Plasma Therapy: A New Flair of Hope in the Fight Against Novel Corona Virus Pandemic (COVID-19). Nano Life. 2020;2050004. DOI:10.1142/S179398442050004X
  • Pankaj Garg. Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy. J Cancer Res Ther. 2019;15(8):1–10. DOI:10.4103/jcrt.JCRT_218_18 (SCI; IF=1.331)
  • Pankaj Garg, Hazra DK. Conjugation of antibodies with radiogold nanoparticles, as an effector targeting agents in Radio-bio conjugate cancer therapy: Optimized labeling and biodistribution results. Indian Journal of Nuclear Medicine. 2017;32:302–309.
  • Pankaj Garg. The genomic effects of radiation exposure: induction of cancers and genetic aberrations in mammalian cells. Research Journal of Environment and Chemistry. 2023. (Accepted)
  • Pankaj Garg. Paracetamol determination in biological fluids using advanced electrochemical sensors: A systematic review. (Communicated to Materials Today, 2023).
  • Sharma Abhishek, Pankaj Garg, Kumar Mukesh. Analytical Method Development and Validation: Quantitative Estimation for Assay of Revefenacin in Pharmaceutical Dosage Form by RP-HPLC Method. Indian Drugs. 2025;62:44–51. https://doi.org/10.53879/id.62.03.14788
  • D.K. Hazra Pankaj Garg. Pretargeting in Radio-bioconjugate therapy: With reference to Rhenium Re-186, Gold Au-199 Lutetium Lu-177 as candidate therapy isotopes. Indian Journal of Nuclear Medicine. 2007;22(1):1–8.
  • D.K. Hazra, A.K. Gupta, S. Saxena, S.K. Sharma, P.K. Hazra, S. Gupta, P. Garg. Radio-Immuno targeting in India with special reference to hepatic metastases: Recent advances. IAEA-CN-130 / ISTR-2005; TECDOC, pp.135–137.
  • Padmallika K. Hazra, Daya Hazra, Arun Gupta, Pankaj Garg. Optimization of antibody constructs for Radioimmunotherapy: Evaluating multi Fab constructs. Journal of Nuclear Medicine. 2006;47(Suppl 1):414–416.
  • P.H. Khanna, D.K. Hazra, A.K. Gupta, P. Garg, P.K. Gangwar, A. Kumar. Modulating tumour uptake of a therapy radiobioconjugate by external intervention: What is the best method. Indian Journal of Nuclear Medicine. 2007;22(4):104–105.
  • P. Garg, D.K. Hazra, A.K. Gupta, P.H. Khanna, A. Taneja. Small animals in radio-pharmaceutical research: With particular reference to radio-bioconjugate targeting. Indian Journal of Nuclear Medicine. 2007;22(4):111.
  • P. Garg, D.K. Hazra, A.K. Gupta, P.H. Khanna, P.K. Gangwar, N.K. Sharma, A. Taneja. Biodistribution of radio-labeled biotin vis-a-vis biodistribution of radio-labeled gamma-globulin. Indian Journal of Nuclear Medicine. 2006;22(4):80.
  • D.K. Hazra, P. Garg, A.K. Gupta, P.H. Khanna, P.K. Gangwar, N.K. Sharma. Radio-labeling stem cells: An urgent need in nuclear medicine. Indian Journal of Nuclear Medicine. 2006;22(4):80–81.
  • D.K. Hazra, A.K. Gupta, P. Garg, P.H. Khanna, P.K. Gangwar, N.K. Sharma. Technetium labeling of Biotin: A model for Rhenium labeling. Indian Journal of Nuclear Medicine. 2005;20(4):103–105.
  • D.K. Hazra, A.K. Gupta, S. Gupta, P.H. Khanna, P.K. Gangwar, P. Garg. Patient Hazards in Radio-bioconjugate Therapy. Indian Journal of Nuclear Medicine. 2004;19(4):154.
  • D.K. Hazra, A.K. Gupta, P.H. Khanna, S. Gupta, P.K. Gangwar, P. Garg. Combination of Radio-bioconjugate Therapy with Other Modalities. Indian Journal of Nuclear Medicine. 2004;19(4):155.
  • Pankaj Garg. Radiolabeling of antibodies in Cancer Therapy: Possible linkage to nanoparticle therapy with radiolabeled Gold. National Conference on Nano Devices, Modeling, Simulation Fabrication (NCND-2015), Abstract Issue, p.66.

Conferences / Seminar / Workshop

+
  • Oral Paper Presentation at “National Conference on Biotechnology Environment, jointly organized by Jamia Millia Islamia National Environment Science Academy (NESA, New Delhi)”.
  • MHRD-GIAN course on Advanced Nanomaterials in Disease Diagnosis and Imaging at NIT Hamirpur.
  • Prevention and Treatment of Cancer by Nano Materials and Other Molecule Aspects (IIT Gandhinagar).
  • International Workshop cum Conference on Emerging Trends in Applied Sciences (selected among top three best paper awarded), Agra University, Agra.
  • National Conference on Nano-Devices, Modeling, Simulation and Fabrication – Hindustan Engineering College, Agra.
  • National Conference on Emerging Trends in Pharma and Bio-Tech Research, Anand College, Agra.
  • Workshop (organized) on Application of NMR IR Spectroscopy in Characterization of Compounds (GLA University, Mathura).
  • National Seminar on Detection and Treatment of Cancer Using Nano Conventional Technologies, GLA University.
  • Workshop on Application of Nanomaterial in Modern Technology, GLA University, Mathura.
  • International Conference on Nanomaterial Functional Material, organized by BITS Pilani.

Subjects Taught

+
  • Teaching Engineering Chemistry, both theory and practical, and Environmental Studies to B.Tech. students.
  • Teaching Green Chemistry to M.Sc. students.
  • Contributing to the writing of science books and research-related articles for reputed journals and publishing houses.
  • Selected as the departmental best faculty in teaching excellence for consecutive years.

Research Interest

+
Medicinal Chemistry especially Cancer- (Nanotech Reinforcement in Cancer Therapeutics), Bio-molecular aspects of treating Cancer, phytochemical remediation and chemical speciation.

Funded Research Projects

+
  • Co-Principal Investigator (Co-PI) in a project entitled “Development of thermally stable radiation resistant organo-silicate based paint formulations for corrosion control for high temperature applicability” approved and funded by Board of Research in Nuclear Sciences (BRNS, Mumbai), 2018.
  • Research Associate (RA) in an ICMR funded project “Development and study of phytochemical embedded metal nanoparticles for possible inhibition of tumor growth.”
  • Junior Research Fellow (JRF) of Lady Tata Memorial, Mumbai, on a research project entitled “Development and study of Novel Radio-labeled Biotin (Vit. H) compounds, suitable to use for radio-immuno targeting in Cancer.”
GLA Virtual Tour Admission Query

By submitting this form, I agree to receive notifications from the University in the form of SMS/E-mail/Call.

Graduate
  • B.Tech Programs
  • UG Programs
  • Lateral Entry
Post Graduate
  • M.Tech Programs
  • PG Programs
Doctoral
  • Doctoral Programs
Diploma
  • Diploma Programs
Admissions Helpline
Apply Online GLA
View All Contact Details GLA
Pay Online GLA
Programs
Admissions
Contact Us
Menu